project id: TCGA-CESC; case submitter id: TCGA-EK-A2RE; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 9.0; age at index: 26; days to birth: -9743; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1984; age at diagnosis: 9743; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic t: T2a2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 57.0; figo stage: Stage IIA; icd 10 code: C53.9; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 364; initial weight: 120.0; oct embedded: false; preservation method: Unknown; sample id: 7bcf54b6-3ffa-4014-92c6-51a7099e6f02; sample submitter id: TCGA-EK-A2RE-01A; portion id: aba2732e-be90-4392-b921-45c8012e99d1; portion submitter id: TCGA-EK-A2RE-01A-11; slide id: 6169ccd1-7e88-4a3a-a94e-6b3bfd2161a0; slide submitter id: TCGA-EK-A2RE-01A-01-TS1; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 4.0; percent normal cells: 10.0; percent stromal cells: 19.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;